ARTICLE | Company News
Medarex and Athersys in antibody deal
August 16, 2000 7:00 AM UTC
Athersys (Cleveland, Ore.) will use its random activation of gene expression (RAGE) proteomics technology to generate 10 disease-related antigen targets and MEDX will use its HuMAb-Mouse technology to...